Literature DB >> 11982310

Tick-borne relapsing fever in North America.

Mark S Dworkin1, Tom G Schwan, Donald E Anderson.   

Abstract

Relapsing fever is characterized by recurring episodes of fever and nonspecific symptoms (e.g., headache, myalgia, arthralgia, shaking chills, and abdominal complaints). The illness is caused by an infection from the Borrelia species (spirochetes) that may be acquired through the bite of an infected tick (Ornithodoros species) or contact with the hemolymph of an infected human body louse (Pediculus humanus). In North America, most cases have been acquired in the western United States, southern British Columbia, and few cases have been reported from Mexico. Most cases have been acquired from exposure to rustic tick-infested cabins and caves. This article reviews relapsing fever, especially tick-borne relapsing fever in North America.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11982310     DOI: 10.1016/s0025-7125(03)00095-6

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  48 in total

1.  Preventing broken Borrelia telomeres: ResT couples dual hairpin telomere formation with product release.

Authors:  Julien Briffotaux; Kerri Kobryn
Journal:  J Biol Chem       Date:  2010-10-14       Impact factor: 5.157

2.  Antigenic variation by Borrelia hermsii occurs through recombination between extragenic repetitive elements on linear plasmids.

Authors:  Qiyuan Dai; Blanca I Restrepo; Stephen F Porcella; Sandra J Raffel; Tom G Schwan; Alan G Barbour
Journal:  Mol Microbiol       Date:  2006-06       Impact factor: 3.501

3.  Tick-borne relapsing fever in pregnancy.

Authors:  Haseena Hussein; Adrienne Showler; Darrell H S Tan
Journal:  CMAJ       Date:  2013-08-12       Impact factor: 8.262

4.  Oms38 is the first identified pore-forming protein in the outer membrane of relapsing fever spirochetes.

Authors:  Marcus Thein; Ignas Bunikis; Katrin Denker; Christer Larsson; Sally Cutler; Michel Drancourt; Tom G Schwan; Reinhard Mentele; Friedrich Lottspeich; Sven Bergström; Roland Benz
Journal:  J Bacteriol       Date:  2008-08-29       Impact factor: 3.490

5.  Phylogenetic analysis of the spirochetes Borrelia parkeri and Borrelia turicatae and the potential for tick-borne relapsing fever in Florida.

Authors:  Tom G Schwan; Sandra J Raffel; Merry E Schrumpf; Paul F Policastro; Julie A Rawlings; Robert S Lane; Edward B Breitschwerdt; Stephen F Porcella
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  Differential telomere processing by Borrelia telomere resolvases in vitro but not in vivo.

Authors:  Yvonne Tourand; Troy Bankhead; Sandra L Wilson; Adrienne D Putteet-Driver; Alan G Barbour; Rebecca Byram; Patricia A Rosa; George Chaconas
Journal:  J Bacteriol       Date:  2006-08-25       Impact factor: 3.490

7.  Immunological Responses to the Relapsing Fever Spirochete Borrelia turicatae in Infected Rhesus Macaques: Implications for Pathogenesis and Diagnosis.

Authors:  Monica E Embers; Aparna Krishnavajhala; Brittany A Armstrong; Michael W Curtis; Bapi Pahar; Hannah K Wilder; Michael S Allen; Paul A Beare; Nicole R Hasenkampf; Job E Lopez
Journal:  Infect Immun       Date:  2019-03-25       Impact factor: 3.441

8.  Tick-borne relapsing fever and Borrelia hermsii, Los Angeles County, California, USA.

Authors:  Tom G Schwan; Sandra J Raffel; Merry E Schrumpf; Merry E Schrumpf; Larry S Webster; Adriana R Marques; Robyn Spano; Michael Rood; Joe Burns; Renjie Hu
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

9.  Identification of conserved antigens for early serodiagnosis of relapsing fever Borrelia.

Authors:  Job E Lopez; Stephen F Porcella; Merry E Schrumpf; Sandra J Raffel; Carl H Hammer; Ming Zhao; Mary Ann Robinson; Tom G Schwan
Journal:  Microbiology (Reading)       Date:  2009-05-14       Impact factor: 2.777

10.  Diversity and distribution of Borrelia hermsii.

Authors:  Tom G Schwan; Sandra J Raffel; Merry E Schrumpf; Stephen F Porcella
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.